Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
University of California v. Broad Institute, Inc.
Case Number:
17-1907
Court:
Nature of Suit:
Companies
Sectors & Industries:
-
September 11, 2018
CRISPR Patent Ruling May Push Warring Sides To A Deal
The Federal Circuit's decision Monday rejecting the University of California's efforts to secure control over patents on the breakthrough gene-editing system CRISPR in a fight with the Broad Institute leaves an unsettled patent landscape for the technology that could spur the parties to strike a deal, attorneys say.
-
September 10, 2018
Fed. Circ. Backs Harvard, MIT Over UC In CRISPR Patent War
The Federal Circuit on Monday rejected the University of California's bid for control over patents on the breakthrough gene-editing system CRISPR, turning away its challenge to patents on the technology to issued to a research institute associated with Harvard and MIT.
-
April 30, 2018
Berkeley Defends Bid To Overrule PTAB In CRISPR Row
Researchers from the University of California, Berkeley and the University of Vienna fended off pointed questioning Monday from a Federal Circuit panel on their effort to nix a patent for gene-editing technology CRISPR-Cas9, held by the Massachusetts-based Broad Institute.
-
July 26, 2017
UC Urges Fed. Circ. To Nix 'Unjust' Gene Editing Patent Ruling
The University of California urged the Federal Circuit Tuesday to overturn a Patent Trial and Appeal Board decision favoring a research institute associated with Harvard and MIT in a hotly contested patent dispute over the breakthrough gene-editing technology CRISPR, calling the ruling “profoundly erroneous” and "unjust."
-
April 13, 2017
Berkeley Appeals PTAB Ruling In MIT, Broad CRISPR Dispute
Researchers from the University of California, Berkeley and the University of Vienna have appealed a Patent Trial and Appeal Board decision finding no overlap between their CRISPR patents and those of the Massachusetts-based Broad Institute, furthering the IP battle between elite teams of scientists over the revolutionary gene-editing technology.